文献速递乳腺癌放疗

DBCG HYPO试验中乳腺硬化与照射体积:年龄、吸烟和追加照射的影响

Breast induration and irradiated volume in the DBCG HYPO trial: The impact of age, smoking, and boost.
PubMed 文献 · Radiother Oncol · 2024-10-10

基于DBCG HYPO III期试验中1333例接受全乳放疗患者的计划分析,≥65岁患者乳腺2-3级硬化与照射体积相关(小/大体积10%/22%,p=0.005),50-64岁患者无此关联(11%对11%,p=0.82)。吸烟使硬化频率翻倍,<50岁接受追加照射患者存在体积效应(5%/21%,p=0.002)。

要点

  • ≥65岁患者乳腺2-3级硬化与照射体积相关:小/大体积10%/22%(p=0.005)。
  • 50-64岁患者硬化频率与照射体积无关:小/大体积均为11%(p=0.82)。
  • 吸烟使硬化频率翻倍,与照射体积和年龄无关。

核心结论

  • ≥65岁患者照射乳腺体积与3年乳腺硬化频率存在关联,而50-64岁患者未见关联。
  • 吸烟使硬化风险翻倍,与照射体积和年龄无关。
  • <50岁接受追加照射患者存在剂量-硬化关系。

研究设计与样本

  • DBCG HYPO III期随机试验,将≥41岁患者随机分配至40 Gy/15次或50 Gy/25次全乳放疗。
  • 分析1333例丹麦患者的放疗计划,采用逻辑回归评估硬化与照射体积、年龄、吸烟状态及追加照射的关联。
  • 对<50岁或切缘狭窄(<2 mm)患者给予序贯追加照射。

主要发现

  • 1333例患者中178例(13%)出现2-3级乳腺硬化。
  • 1135例仅接受全乳放疗患者中,≥65岁组(n=343)小/大照射体积硬化频率为10%/22%(p=0.005),50-64岁组(n=792)小/大体积均为11%(p=0.82)。
  • 吸烟使硬化频率翻倍,与照射体积和年龄无关。
  • <50岁患者(n=156)均接受追加照射,小/大体积硬化频率为5%/21%(p=0.002)。
  • ≥50岁接受追加照射患者42例中14例(33%)出现2-3级硬化,因患者数少p值>0.05。

关键数值与推荐

  • ≥65岁仅全乳放疗患者小/大照射体积硬化频率10%/22%(p=0.005)。
  • 50-64岁仅全乳放疗患者小/大照射体积硬化频率均为11%(p=0.82)。
  • <50岁接受追加照射患者小/大照射体积硬化频率5%/21%(p=0.002)。
  • ≥50岁接受追加照射患者42例中14例(33%)出现2-3级硬化,p值>0.05。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • ≥50岁接受追加照射患者中2-3级硬化分析因患者数少p值>0.05。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the association between irradiated breast volume and grade 2-3 breast induration three years after radiotherapy in the phase III Danish Breast Cancer Group HYPO trial randomizing patients ≥ 41 years to whole breast irradiation (WBI) with 40 Gy/15fr versus 50 Gy/25fr. METHODS: Treatment plans were available for all Danish patients. Associations between frequency of induration and irradiated volume, age, smoking status, and boost were assessed by logistic regression. A sequential boost was given to patients < 50 years or in case of a narrow (<2 mm) resection margin. RESULTS: RT plans from 1,333 patients were analyzed with 178 (13 %) having grade 2-3 induration. 1135 patients had only WBI. For this group, induration was correlated with irradiated breast volume for patients ≥ 65 years (n = 343, 10 %/22 % for small/large irradiated volumes, p = 0.005) but not for patients aged 50-64 years (n = 792, 11 % for both small and large volumes, p = 0.82). Smoking doubled the frequency irrespective of irradiated volume and age. All patients < 50 years (n = 156) had a boost. A volume effect was found for this group (5 %/21 % induration for small/large volume, p = 0.002). 42 patients ≥ 50 years had a boost and 14 (33 %) had grade 2-3 induration, however, with a p-value > 0.05 due to the few numbers of patients. CONCLUSION: A relationship between irradiated breast volume and 3-year frequency of breast induration was found for patients ≥ 65 years, whilst not for patients aged 50-64 years. Smoking doubled the risk of induration irrespective of volume and age. A dose-induration relationship was seen for boost patients < 50 years.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Thomsen MS, Alsner J, Lutz CM, et al. Breast induration and irradiated volume in the DBCG HYPO trial: The impact of age, smoking, and boost. Radiother Oncol. 2024. PMID: 39395667. doi:10.1016/j.radonc.2024.110574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。